| ||
| New drug could tackle hard-to-treat form of breast cancer Telegraph.co.uk A new drug could be the first effective targeted treatment against Triple Negative Breast Cancer, which affects one in seven sufferers of the disease. The drug, known as BSI-201, could help tackle the hard-to-treat form of breast cancer. ... See all stories on this topic » | ||
| Michigan Matters Stem cell research, autism, and Michigan's future Detroit Free Press By Carol Cain With the backdrop of a global stem cell conference about to roll into the Motor City, billionaire A. Alfred Taubman is continuing his mission of making Michigan a hub of medical research. Taubman, the outspoken 86-year-old businessman who ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment